BAX stock: buy or sell?
February 25th, 2020
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments.
Should I buy BAX stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that fits your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Baxter International stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Baxter International stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't find any rating for BAX stock for the last month.
BAX stock analysis
Baxter International shares eased -2.84% to $86.99 today.
Shares of Baxter International eased a horrible -2.84% and closed at $86.99. Since price and SMA200d lines crossed up on November, BAX climbed $7.10 (8.89%). In the last 29 days when SMA50d and SMA100d crossed up, BAX price slipped $-3.79 per share (-4.17%). On February 6th, BAX hit new all time highs, pushing higher previous ATH of $91.87 recorded on January 21st. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Baxter International ended this week at $86.99 and plunged a spooky -6.13%.
Not so far away is the last all-time high Baxter International marked early February. By mid November 2019 BAX price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since SMA20d and SMA40w crossed up early April, BAX price climbed $6.97 per share (8.71%).
BAX stock price history
BAX IPO was on October 27th, 1981 at $0.00 per share1. Since then, BAX stock grew a inf%, with an average of inf% per year. If you had invested $1,000 in BAX stock in 1981, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
BAX stock historical price chart
BAX stock reached all-time highs on Feb/6 with a price of $95.00.
BAX stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' BAX stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price target for Baxter International stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on April, Baxter International . As soon as we get its posted EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Baxter International annual revenues escalated a decent 5.36% to $11,127.00 M USD from $10,561.00 marked in 2017. When comparing 2018 vs 2017, however, profit margin (that is, the net income divided by revenues) rose a 7.81% to 14.60%. Baxter International fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Baxter International TTM sales up to March 2019 were $11,082.00 and income $1,582.00 million USD. If we compare this TTM figures with the last reported annuality, we can review Baxter International business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, stayed stable a tight -0.40%. In the same way, profit margin (net income/revenues) remained stable at 14.60%.
|2013||$15,260 M||-||$2,010 M13.2%||-|
|2014||$16,671 M||9.25%||$2,497 M15.0%||24.23%|
|2015||$9,968 M||-40.21%||$968 M9.7%||-61.23%|
|2016||$10,163 M||1.96%||$4,965 M48.9%||412.91%|
|2017||$10,561 M||3.92%||$717 M6.8%||-85.56%|
|2018||$11,127 M||5.36%||$1,624 M14.6%||126.50%|
|TTM||$11,082 M||-0.40%||$1,582 M14.3%||-2.59%|
Quarterly financial resultsBaxter International reported $2,632.00 M in revenues for 2019-Q1, a -7.36% decline compared to previous quarter. Reported quarter income marked $347.00 million with a profit margin of 13.18%. Profit margin stayed stable a 0.93% compared to previous quarter when profit margin was 12.25%. When comparing sales to same quarter last year, Baxter International sales marked an unpleasant correction and declined a -1.68%.
|2017-Q2||$2,610 M||-||$264 M10.1%||-|
|2017-Q3||$2,710 M||3.83%||$248 M9.2%||-6.06%|
|2017-Q4||$2,774 M||2.36%||$-71 M-2.6%||-128.63%|
|2018-Q1||$2,677 M||-3.50%||$389 M14.5%||-647.89%|
|2018-Q2||$2,842 M||6.16%||$343 M12.1%||-11.83%|
|2018-Q3||$2,767 M||-2.64%||$544 M19.7%||58.60%|
|2018-Q4||$2,841 M||2.67%||$348 M12.2%||-36.03%|
|2019-Q1||$2,632 M||-7.36%||$347 M13.2%||-0.29%|
Baxter International ownershipWhen you are planning to invest in a company, it's worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Baxter International, 0.11% of all outstanding shares are owned by its staff.
Bearish positions for BAX stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$44.4 B|
|Total shares||510.6 M|
|Float shares||509.6 M|
|- Institutional holdings (%)||86.7%|
|- Insider holdings (%)||0.1%|
|Shares in short selling||0.0%|
|Tuesday, February 25th, 2020|
|Day range||$86.20 - $90.23|
|Average true range||$1.90|
|50d mov avg||$88.33|
|100d mov avg||$85.29|
|200d mov avg||$83.75|
Baxter International performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We picked as the bechmarking frame for Baxter International stock.